A phase 1/2 trial of Coversin in the inflammatory-mediated eye disorder Atopic Keratoconjunctivitis (AKC)
Phase of Trial: Phase I/II
Latest Information Update: 30 Sep 2018
At a glance
- Drugs Nomacopan (Primary)
- Indications Keratoconjunctivitis
- Focus Therapeutic Use
- 30 Sep 2018 Status changed from planning to recruiting, according to an Akari Therapeutics media release.
- 17 Aug 2018 According to an Akari Therapeutics media release, this study is expected to start in Q3 2018, with data anticipated Q1 2019.
- 09 Feb 2018 New trial record